Furthermore, spiroepoxide biscurcumin and primaquine significantly modulated CD9 tetraspanin levels (Figure 5 L) , while biscurcumin, primaquine, and doxorubicin modulated ALIX levels (Figure 5 K), although this failed to reach significance.
← all excerpts
A Rapid, Convergent Approach to the Identification of Exosome Inhibitors in Breast Cancer Models.
1
—
—